Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Availability Heuristic01:08

The Availability Heuristic

7.2K
A heuristic is a general problem-solving framework (Tversky & Kahneman, 1974). You can think of these as mental shortcuts that are used to solve problems. Different types of heuristics are used in different types of situations, and the impulse to use a heuristic occurs when one of five conditions is met (Pratkanis, 1989):
7.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visceral muscle dysmotility syndrome in systemic lupus erythematosus: which is the role of 18 fluorodeoxyglucose-positron emission tomography-computed tomography? A clinical case and literature review.

Reumatismo·2024
Same author

Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab.

Reumatismo·2020
Same author

In memory of Dr. Luis Espinoza.

Reumatismo·2020
Same author

Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study.

Reumatismo·2020
Same author

Association between clinical specialty setting and disease management in patients with psoriatic arthritis: results from LOOP, a cross-sectional, multi-country, observational study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Occult axial involvement in patients with psoriatic arthritis mutilans: a case report.

Reumatismo·2019
Same journal

Delayed referral, socioeconomic status, and disease characteristics as factors associated with disabilities in rheumatoid arthritis patients: a multicenter observational study.

Reumatismo·2026
Same journal

Telerheumatology to improve first access outcomes in outpatients: a prospective monocentric pilot study.

Reumatismo·2026
Same journal

Hypocomplementemic urticarial vasculitis: a rare presentation revealing systemic lupus erythematosus and Sjögren's disease.

Reumatismo·2026
Same journal

Is there still someone laughing at Christopher Columbus?

Reumatismo·2026
Same journal

Concurrent herpetic hypertensive anterior uveitis and cytomegalovirus retinitis in a non-HIV patient with melanoma differentiation-associated gene-5 dermatomyositis: intravenous immunoglobulin comes to the rescue.

Reumatismo·2026
Same journal

Myasthenic syndrome in systemic lupus erythematosus successfully treated with plasma exchange: through one of the unexplored faces of neuropsychiatric involvement.

Reumatismo·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

48.7K

[Not Available].

F M Perrotta1, E Lubrano

  • 1Academic Rheumatology Unit, Department of Medicine and Health Sciences Vincenzo Tiberio, University of Molise, Campobasso. f.perrotta85@gmail.com.

Reumatismo
|September 10, 2016
PubMed
Summary
This summary is machine-generated.

New biologic drugs targeting specific inflammatory pathways have demonstrated efficacy and safety in treating psoriatic arthritis (PsA), improving patient outcomes and quality of life.

More Related Videos

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

25.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

22.8K

Related Experiment Videos

Last Updated: Mar 15, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

48.7K
Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

25.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

22.8K

Area of Science:

  • Rheumatology
  • Immunology
  • Dermatology

Background:

  • Psoriatic arthritis (PsA) is a chronic inflammatory condition impacting joints, skin, and entheses.
  • Traditional treatments like anti-TNF drugs have improved PsA management, but new therapeutic targets are emerging.
  • Understanding PsA's complex pathogenic mechanisms has driven the development of novel targeted therapies.

Purpose of the Study:

  • To review clinical trials supporting the approval of new drugs for psoriatic arthritis.
  • To highlight the efficacy and safety of novel agents targeting specific inflammatory pathways in PsA.
  • To discuss the integration of these new treatments into current EULAR and GRAPPA recommendations.

Main Methods:

  • Review of randomized clinical trials for ustekinumab, secukinumab, and apremilast in PsA.
  • Analysis of data on symptom reduction, functional improvement, and radiographic progression.
  • Evaluation of safety profiles and adverse events reported in clinical studies.

Main Results:

  • Ustekinumab, secukinumab, and apremilast demonstrated significant efficacy in treating PsA symptoms and signs.
  • These agents target key pro-inflammatory cytokines and intracellular pathways involved in PsA pathogenesis.
  • Clinical trials confirmed the safety and tolerability of these new drugs in PsA patients.

Conclusions:

  • New targeted therapies offer effective treatment options for psoriatic arthritis.
  • These advancements represent a significant step forward in managing PsA, addressing skin, joint, and entheseal inflammation.
  • The approval and inclusion of these drugs in guidelines underscore their importance in modern PsA treatment.